Regulus Therapeutics Inc. (RGLS) Dividend History

Regulus Therapeutics Inc. is a biotechnology company focused on the development of medicines targeting microRNAs to treat various diseases, including cancer, fibrosis, and neurodegenerative disorders. Founded as a collaboration between pharmaceutical and biotechnology leaders, it leverages its expertise in RNA biology to develop innovative therapeutics.

4224 Campus Point Court, San Diego, CA, 92121
Phone: 858-202-6300
Website:

Dividend History

Regulus Therapeutics Inc. currently does not pay dividends

Company News

  • Novartis announces data from a subgroup analysis of the NATALEE trial, showing that Kisqali plus endocrine therapy reduced the risk of recurrence in pre-menopausal and younger patients with early breast cancer.

    GlobeNewswire Inc.
  • Halper Sadeh LLC is investigating several companies for potential violations of securities laws and breaches of fiduciary duties to shareholders, including Regulus Therapeutics, Kronos Bio, Longevity Health Holdings, and Southern States Bancshares.

    GlobeNewswire Inc.
    Featured Companies: KRON SSBK XAGE
  • Novartis has agreed to acquire Regulus Therapeutics, a clinical-stage biopharmaceutical company developing microRNA therapeutics for kidney diseases, for an initial payment of $800 million. The deal could reach $1.7 billion if Regulus' lead product candidate, farabursen, gains regulatory approval.

    Benzinga
  • Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan cut the price target for Sea Limited (NYSE:SE) from $84 to $78. JP Morgan analyst Ranjan Sharma downgraded the stock from Overweight to Neutral. Sea shares gained 0.6% to close at $75.89 on Monday. See how other analysts view this stock. Morgan Stanley raised the price target for Birkenstock Holding plc (NYSE:BIRK) from $44 to $58. Morgan Stanley analyst Edouard Aubin maintained an Equal-Weight rating. Birkenstock shares fell 2.8% to close at $59.78 on Monday. See how other analysts view this stock. TD Cowen boosted Credo Technology Group Holding Ltd (NASDAQ:CRDO) price target from $24 to $35. TD Cowen analyst Matt Ramsay upgraded the stock from Hold to Buy. Credo ...Full story available on Benzinga.com

    Benzinga
    Featured Companies: BALL BIRK CHRW CPRI CRDO ETSY NET
  • Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. Limbach said it sees FY24 revenue of $510 million to $530 million, versus market estimates of $541.1 million. Limbach shares dipped 14.7% to $42.42 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Aptorum Group Limited (NASDAQ: APM) shares climbed 91% to $8.27. Presto Automation Inc. (NASDAQ: PRST) shares jumped 65.2% to $0.3715 after jumping 15% on Wednesday. Cheer Holding, Inc. (NASDAQ: CHR) surged 43.3% to $3.77 following full year 2023 financial results. WiMi Hologram Cloud Inc. (NASDAQ: WIMI) shares gained 36.9% to $1.5060. Turtle Beach Corporation (NASDAQ: HEAR) gained 29.2% to $14.25 after the company announced the acquisition of PDP and its intention to launch a modified "Dutch Auction" Tender Offer. The company also reported fourth-quarter financial results. VAALCO Energy, Inc. (NYSE: EGY) rose 22% to $5.45 after the company reported better-than-expected fourth-quarter financial results. Build-A-Bear Workshop, Inc. (NYSE: BBW) gained 15.7% to $29.20 after the company reported better-than-expected fourth-quarter EPS but missed on revenue. Additionally, the company guided FY24 revenue growth on a low-to-mid-single-digit percentage basis. Unicycive Therapeutics, Inc. (NASDAQ: UNCY) gained 15% to $1.5980. The company announced a $50 million private placement. DICK'S Sporting Goods, Inc. (NYSE: DKS) rose 14.8% to $215.70 after the company reported strong fourth-quarter results and issued guidance above consensus estimates. Lithium Americas Corp. (NYSE: LAC) surged 14.6% to $6.57 after the company announced that it received a conditional commitment from the U.S. Department of Energy for a $2.26 billion loan under the Advanced Technology Vehicles Manufacturing Loan Program for financing the construction of the processing facilities at Thacker Pass in Nevada. Auddia Inc. (NASDAQ: AUUD) shares gained 11.5% to $3.07 after falling 6% on ...

    Benzinga
Dividend data last updated 06/07/2025 16:48:48 UTC